Analysis of Anti–Vascular Endothelial Growth Factor Injection Claims Data in US Medicare Part B Beneficiaries From 2012 to 2015
Author:
Affiliation:
1. Department of Ophthalmology, Vanderbilt University School of Medicine, Nashville, Tennessee
2. Department of Biostatistics, Vanderbilt University, Nashville, Tennessee
Publisher
American Medical Association (AMA)
Subject
Ophthalmology
Link
https://jamanetwork.com/journals/jamaophthalmology/article-pdf/137/8/921/17773810/jamaophthalmology_berkowitz_2019_oi_190040.pdf
Reference49 articles.
1. Vascular endothelial growth factor is a secreted angiogenic mitogen.;Leung;Science,1989
2. Vascular permeability factor, an endothelial cell mitogen related to PDGF.;Keck;Science,1989
3. Inhibition of vascular endothelial growth factor prevents retinal ischemia–associated iris neovascularization in a nonhuman primate.;Adamis;Arch Ophthalmol,1996
4. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.;Aiello;Proc Natl Acad Sci U S A,1995
5. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy.;Robinson;Proc Natl Acad Sci U S A,1996
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Incidence of Blepharoptosis Following Intravitreal Anti–Vascular Endothelial Growth Factor Injections;American Journal of Ophthalmology;2024-09
2. The toxic effects of polystyrene microplastic/nanoplastic particles on retinal pigment epithelial cells and retinal tissue;Environmental Science and Pollution Research;2024-09-01
3. Real-World Research on Retinal Diseases Using Health Claims Database: A Narrative Review;Diagnostics;2024-07-19
4. Evidence-Based Use of Bevacizumab in the Management of Neovascular Age-Related Macular Degeneration;Ophthalmic Surgery, Lasers and Imaging Retina;2024-03
5. Häufigkeit und Wirkstoffverteilung intravitrealer Injektionen in deutschen Zentren 2015 bis 2021 – eine oregis-Studie;Die Ophthalmologie;2024-02-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3